Quality of Life is the Ultimate Endpoint

Did you know that only 1 in 8 drugs in development makes it to market? It is estimated by the Manhattan Institute that $4.3 billion out of every $5.8 billion spent on research and development of new therapies is misspent. That cost is felt in time and money, but even more so in lost opportunity. It’s tragic that progress is so slow and expensive. For all of the monetary and human resources dedicated to pharmaceutical R&D, the odds remain heavily stacked against breakthrough research ever making it to market. There’s even a name for this phenomenon: Eroom’s Law, the opposite of Moore’s, in spelling and effect alike. The cost of developing a new drug doubles roughly every nine years. Drug prices are so high, in part, because it is so costly to develop them in the first place. Rare diseases are left untreated, because only blockbusters have a chance of recouping costs. Roll-ups and PE-style consolidation are now standard. Deep pockets, faced with escalating costs, choose to buy innovation instead of fund it, pushing lopsided risk as far downstream as possible. The pharmaceutical industry has a noble and essential purpose. It is charged with developing innovative new treatments that cure acute diseases and help manage chronic ones. In fact, we can’t imagine a better way to spend one’s time or money. What is the biggest pain point on earth? Pain itself, we’d argue. Improving pharma’s own outcomes is an entrepreneurial endeavor worthy...
Source: EyeForPharma - Category: Pharmaceuticals Authors: Source Type: news

Related Links:

Publication date: Available online 18 January 2020Source: Clinica Chimica ActaAuthor(s): Guodong Zhao, Yong Ma, Hui Li, Shiming Li, Yun Zhu, Xiaoyu Liu, Shangmin Xiong, Yi Liu, Jin Miao, Sujuan Fei, Minxue Zheng, Xiangwei ZhaoAbstractBackgroundMethylated SFRP2 was previously reported as a non-invasive biomarker for colorectal cancer (CRC) detection with a relatively low sensitivity for early stage CRC. The purpose of this study was to evaluate the performance of a new plasma based CRC screening assay, SpecColon test, which tested methylated SFRP2 and SDC2 simultaneously in a single qPCR reaction, in detecting CRC and advan...
Source: Clinica Chimica Acta - Category: Laboratory Medicine Source Type: research
Conclusions: HRQoL correlates with disease severity, and patients with UC have lower HRQoL than the general population. The most important treatment attribute was efficacy, but patients also would like to avoid steroids, value fast onset of effect and prefer oral formulations. PMID: 31944145 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
Conclusion. This large systematic review of over 11,000 participants demonstrates that topical diclofenac is effective for acute pain, such as sprains and strains, with minimal AEs. The effectiveness of topical diclofenac was also demonstrated in chronic musculoskeletal pain, such as osteoarthritis, but with a higher NNT (worse) compared with acute pain. Again, the incidence of AEs was low. Formulation does play a part in effectiveness, and studies are needed to investigate this further. Studies of chronic pain outside of osteoarthritis would also be helpful. PMID: 31944135 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
Conclusion: Advanced RCC has high morbidity and mortality with an increasing prevalence. Following tyrosine kinase inhibitors, checkpoint inhibitors have a great influence on treatment of advanced RCC, especially the combination of these two strategies. In 2019 these combined strategies demonstrated 5% complete remission with up to 60% objective response rate. While not immediately, but perhaps in the near future, advanced RCC will become a manageable chronic disease, even if a cure is not possible. PMID: 31942809 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
Authors: Oikonomou EK PMID: 31944137 [PubMed - as supplied by publisher]
Source: Expert Review of Molecular Diagnostics - Category: Laboratory Medicine Tags: Expert Rev Mol Diagn Source Type: research
Publication date: Available online 16 January 2020Source: Biosensors and BioelectronicsAuthor(s): Parvin Samadi Pakchin, Marziyeh Fathi, Hossein Ghanbari, Reza Saber, Yadollah OmidiAbstractIn the current study, we report on the design and development of a novel electrochemical immunosensor for the detection of cancer antigen 125 (CA125) oncomarker. Polyamidoamine/gold nanoparticles (PAMAM/AuNPs) were used to increase the conductivity and enhance the number of antibodies (Ab) immobilized on the electrode surface. Three-dimensional reduced graphene oxide-multiwall carbon nanotubes (3DrGO-MWCNTs) were used to modify the glass...
Source: Biosensors and Bioelectronics - Category: Biotechnology Source Type: research
The Redwood City company raised $226 million in three venture rounds after its formation five years ago by Third Rock Ventures.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
Authors: Herring WJ, Ceesay P, Snyder E, Bliwise D, Budd K, Hutzelmann J, Stevens J, Lines C, Michelson D Abstract INTRODUCTION: We evaluated the clinical profile of the orexin receptor antagonist suvorexant for treating insomnia in patients with mild-to-moderate probable Alzheimer's disease (AD) dementia. METHODS: Randomized, double-blind, 4-week trial of suvorexant 10 mg (could be increased to 20 mg based on clinical response) or placebo in patients who met clinical diagnostic criteria for both probable AD dementia and insomnia. Sleep was assessed by overnight polysomnography in a sleep laboratory. The primar...
Source: The Journal of Alzheimers Association - Category: Psychiatry Tags: Alzheimers Dement Source Type: research
CONCLUSION: According to the high percentage of patients diagnosed with vision-threatening DR in this study, an early diagnosis of this complication of diabetes seems to be important. Teleophthalmology enhances patient accessibility to the healthcare system, making early diagnosis of DR easier, with a high degree of satisfaction among patients and healthcare professionals. PMID: 31941342 [PubMed - in process]
Source: Rural and Remote Health - Category: Rural Health Tags: Rural Remote Health Source Type: research
This article presents an experimental investigation of the flame characteristics of the gasoline pool fire. A series of experiments with different pool sizes and mixture contents were conducted to study the combustion behavior of pool fires in atmospheric ...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news
More News: Arthritis | Biology | Biotechnology | Burns | Cancer | Cancer & Oncology | Cardiology | Chronic Pain | Clinical Trials | Crohn's Disease | Diabetes | Endocrinology | Environmental Health | Eyes | Harvard | Health | Heart | Hematology | History of Medicine | Hospital Management | Hospitals | Inflammatory Bowel Disease | Medical Devices | Men | Molecular Biology | Nutrition | Orthopaedics | Pain | Pain Management | Pancreas | Pancreatic Cancer | Pediatrics | Pharmaceuticals | Rare Diseases | Rheumatoid Arthritis | Rheumatology | Science | Sleep Disorders | Sleep Medicine | Sports Medicine | Study